Skip to main content
. 2016 Dec 22;8(5):8143–8153. doi: 10.18632/oncotarget.14106

Figure 5.

Figure 5

18F-FDG PET/CT images before A and after B treatment demonstrating a minimal reduction of glucose metabolism with ΔSUVmax of 6.07% classifying the patient as non responder.